Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50

Saved in:
Bibliographic Details
Published in:Journal of internal medicine 2022-05, Vol.291 (5), p.705-706
Main Authors: Almagro, Pere, Malik, Komal, Martínez‐Camblor, Pablo
Format: Article
Language:English
Subjects:
Acute Coronary Syndrome - drug therapy
Acute coronary syndromes
Administration, Inhalation
Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists - therapeutic use
Bronchodilator Agents - adverse effects
Humans
Pulmonary Disease, Chronic Obstructive - drug therapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3
cites cdi_FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3
container_end_page 706
container_issue 5
container_start_page 705
container_title Journal of internal medicine
container_volume 291
creator Almagro, Pere
Malik, Komal
Martínez‐Camblor, Pablo
description
doi_str_mv 10.1111/joim.13438
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2621268229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2649530386</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3</originalsourceid><addsrcrecordid>eNp9kclKBDEQhoMoOi4XH0ACXkRozdLJpL2JuyiC6LlJZxl7THc0mShz8xF8Rp_EjKMePJhLkuLjo6p-ADYx2sP57I992-1hWlKxAAaYclaQYcUXwQBVrCy4IGgFrMY4RghTxNEyWKEMlXjI0QCEWzOSQbf96AAeJ-ngiwkxRRhzxRnofD_6eHuXapL_sAm-Vw9et05OfIApGqh8choG2ea3VGkyq2RKhimM014H3xkY2vgImyn02Q0ZWgdLVrpoNr7vNXB_enJ3dF5c3ZxdHB1eFYqIoSiIkFpVjGFZKkmkHWqjVNVYhaRFkihmJeJVo5uGWauNYNRUhAnDGsGJJZaugZ259yn452TipO7aqIxzsjc-xZpwgkneDqkyuv0HHfsU-txdpsqKUUQFz9TunFLBxxiMrZ9C2-VRa4zqWRL1LIn6K4kMb30rU9MZ_Yv-rD4DeA68ts5M_1HVlzcX13PpJ2mMlqM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2649530386</pqid></control><display><type>article</type><title>Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Almagro, Pere ; Malik, Komal ; Martínez‐Camblor, Pablo</creator><creatorcontrib>Almagro, Pere ; Malik, Komal ; Martínez‐Camblor, Pablo</creatorcontrib><identifier>ISSN: 0954-6820</identifier><identifier>EISSN: 1365-2796</identifier><identifier>DOI: 10.1111/joim.13438</identifier><identifier>PMID: 35041760</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Acute Coronary Syndrome - drug therapy ; Acute coronary syndromes ; Administration, Inhalation ; Adrenal Cortex Hormones ; Adrenergic beta-2 Receptor Agonists - therapeutic use ; Bronchodilator Agents - adverse effects ; Humans ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Treatment Outcome</subject><ispartof>Journal of internal medicine, 2022-05, Vol.291 (5), p.705-706</ispartof><rights>2022 The Association for the Publication of the Journal of Internal Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3</citedby><cites>FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3</cites><orcidid>0000-0002-8476-4942</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35041760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Almagro, Pere</creatorcontrib><creatorcontrib>Malik, Komal</creatorcontrib><creatorcontrib>Martínez‐Camblor, Pablo</creatorcontrib><title>Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50</title><title>Journal of internal medicine</title><addtitle>J Intern Med</addtitle><subject>Acute Coronary Syndrome - drug therapy</subject><subject>Acute coronary syndromes</subject><subject>Administration, Inhalation</subject><subject>Adrenal Cortex Hormones</subject><subject>Adrenergic beta-2 Receptor Agonists - therapeutic use</subject><subject>Bronchodilator Agents - adverse effects</subject><subject>Humans</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Treatment Outcome</subject><issn>0954-6820</issn><issn>1365-2796</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kclKBDEQhoMoOi4XH0ACXkRozdLJpL2JuyiC6LlJZxl7THc0mShz8xF8Rp_EjKMePJhLkuLjo6p-ADYx2sP57I992-1hWlKxAAaYclaQYcUXwQBVrCy4IGgFrMY4RghTxNEyWKEMlXjI0QCEWzOSQbf96AAeJ-ngiwkxRRhzxRnofD_6eHuXapL_sAm-Vw9et05OfIApGqh8choG2ea3VGkyq2RKhimM014H3xkY2vgImyn02Q0ZWgdLVrpoNr7vNXB_enJ3dF5c3ZxdHB1eFYqIoSiIkFpVjGFZKkmkHWqjVNVYhaRFkihmJeJVo5uGWauNYNRUhAnDGsGJJZaugZ259yn452TipO7aqIxzsjc-xZpwgkneDqkyuv0HHfsU-txdpsqKUUQFz9TunFLBxxiMrZ9C2-VRa4zqWRL1LIn6K4kMb30rU9MZ_Yv-rD4DeA68ts5M_1HVlzcX13PpJ2mMlqM</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Almagro, Pere</creator><creator>Malik, Komal</creator><creator>Martínez‐Camblor, Pablo</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8476-4942</orcidid></search><sort><creationdate>202205</creationdate><title>Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50</title><author>Almagro, Pere ; Malik, Komal ; Martínez‐Camblor, Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute Coronary Syndrome - drug therapy</topic><topic>Acute coronary syndromes</topic><topic>Administration, Inhalation</topic><topic>Adrenal Cortex Hormones</topic><topic>Adrenergic beta-2 Receptor Agonists - therapeutic use</topic><topic>Bronchodilator Agents - adverse effects</topic><topic>Humans</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Almagro, Pere</creatorcontrib><creatorcontrib>Malik, Komal</creatorcontrib><creatorcontrib>Martínez‐Camblor, Pablo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Almagro, Pere</au><au>Malik, Komal</au><au>Martínez‐Camblor, Pablo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50</atitle><jtitle>Journal of internal medicine</jtitle><addtitle>J Intern Med</addtitle><date>2022-05</date><risdate>2022</risdate><volume>291</volume><issue>5</issue><spage>705</spage><epage>706</epage><pages>705-706</pages><issn>0954-6820</issn><eissn>1365-2796</eissn><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>35041760</pmid><doi>10.1111/joim.13438</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-8476-4942</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0954-6820
ispartof Journal of internal medicine, 2022-05, Vol.291 (5), p.705-706
issn 0954-6820
1365-2796
language eng
recordid cdi_proquest_miscellaneous_2621268229
source Wiley-Blackwell Read & Publish Collection
subjects Acute Coronary Syndrome - drug therapy
Acute coronary syndromes
Administration, Inhalation
Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists - therapeutic use
Bronchodilator Agents - adverse effects
Humans
Pulmonary Disease, Chronic Obstructive - drug therapy
Treatment Outcome
title Regarding: Dual versus single long‐acting bronchodilator use could raise acute coronary syndrome risk by over 50
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A25%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regarding:%20Dual%20versus%20single%20long%E2%80%90acting%20bronchodilator%20use%20could%20raise%20acute%20coronary%20syndrome%20risk%20by%20over%2050&rft.jtitle=Journal%20of%20internal%20medicine&rft.au=Almagro,%20Pere&rft.date=2022-05&rft.volume=291&rft.issue=5&rft.spage=705&rft.epage=706&rft.pages=705-706&rft.issn=0954-6820&rft.eissn=1365-2796&rft_id=info:doi/10.1111/joim.13438&rft_dat=%3Cproquest_cross%3E2649530386%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2878-28adc9551a4ca2af7decc9bfc0af0a2c5fa069bdbb5ffde853e9258e5b862f2f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2649530386&rft_id=info:pmid/35041760&rfr_iscdi=true